» Articles » PMID: 22915796

Broad-spectrum Antivirals Against 3C or 3C-like Proteases of Picornaviruses, Noroviruses, and Coronaviruses

Overview
Journal J Virol
Date 2012 Aug 24
PMID 22915796
Citations 206
Authors
Affiliations
Soon will be listed here.
Abstract

Phylogenetic analysis has demonstrated that some positive-sense RNA viruses can be classified into the picornavirus-like supercluster, which includes picornaviruses, caliciviruses, and coronaviruses. These viruses possess 3C or 3C-like proteases (3Cpro or 3CLpro, respectively), which contain a typical chymotrypsin-like fold and a catalytic triad (or dyad) with a Cys residue as a nucleophile. The conserved key sites of 3Cpro or 3CLpro may serve as attractive targets for the design of broad-spectrum antivirals for multiple viruses in the supercluster. We previously reported the structure-based design and synthesis of potent protease inhibitors of Norwalk virus (NV), a member of the Caliciviridae family. We report herein the broad-spectrum antiviral activities of three compounds possessing a common dipeptidyl residue with different warheads, i.e., an aldehyde (GC373), a bisulfite adduct (GC376), and an α-ketoamide (GC375), against viruses that belong to the supercluster. All compounds were highly effective against the majority of tested viruses, with half-maximal inhibitory concentrations in the high nanomolar or low micromolar range in enzyme- and/or cell-based assays and with high therapeutic indices. We also report the high-resolution X-ray cocrystal structures of NV 3CLpro-, poliovirus 3Cpro-, and transmissible gastroenteritis virus 3CLpro- GC376 inhibitor complexes, which show the compound covalently bound to a nucleophilic Cys residue in the catalytic site of the corresponding protease. We conclude that these compounds have the potential to be developed as antiviral therapeutics aimed at a single virus or multiple viruses in the picornavirus-like supercluster by targeting 3Cpro or 3CLpro.

Citing Articles

Structure of coxsackievirus cloverleaf RNA and 3C dimer establishes the RNA-binding mechanism of enterovirus protease 3C.

Dias-Solange D, Le M, Gottipati K, Choi K Sci Adv. 2025; 11(11):eads6862.

PMID: 40073119 PMC: 11900867. DOI: 10.1126/sciadv.ads6862.


Functionalization of a versatile fluorescent sensor for detecting protease activity and temporally gated opioid sensing.

Sescil J, Fiel H, Havens S, Fu E, Li X, Kroning K RSC Chem Biol. 2025; .

PMID: 39975583 PMC: 11835013. DOI: 10.1039/d4cb00276h.


Advancements in the development of antivirals against SARS-Coronavirus.

Kumar M, Baig M, Bhardwaj K Front Cell Infect Microbiol. 2025; 15:1520811.

PMID: 39917633 PMC: 11798951. DOI: 10.3389/fcimb.2025.1520811.


Identifying Natural Products as Feline Coronavirus M Inhibitors by Structural-Based Virtual Screening and Enzyme-Based Assays.

Jiang Z, Piao L, Ren C, Zhang W, Zhu Y, Kong R ACS Omega. 2025; 10(2):2092-2101.

PMID: 39866606 PMC: 11755153. DOI: 10.1021/acsomega.4c08601.


Structural Analysis of Inhibitor Binding to Enterovirus-D68 3C Protease.

Azzolino V, Shaqra A, Ali A, Yilmaz N, Schiffer C Viruses. 2025; 17(1).

PMID: 39861864 PMC: 11768739. DOI: 10.3390/v17010075.


References
1.
Matthews D, Smith W, Ferre R, Condon B, Budahazi G, Sisson W . Structure of human rhinovirus 3C protease reveals a trypsin-like polypeptide fold, RNA-binding site, and means for cleaving precursor polyprotein. Cell. 1994; 77(5):761-71. DOI: 10.1016/0092-8674(94)90059-0. View

2.
Jaulent A, Fahy A, Knox S, Birtley J, Roque-Rosell N, Curry S . A continuous assay for foot-and-mouth disease virus 3C protease activity. Anal Biochem. 2007; 368(2):130-7. DOI: 10.1016/j.ab.2007.05.026. View

3.
Patick A, Binford S, Brothers M, Jackson R, Ford C, Diem M . In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease. Antimicrob Agents Chemother. 1999; 43(10):2444-50. PMC: 89498. DOI: 10.1128/AAC.43.10.2444. View

4.
Hoffmann H, Kunz A, Simon V, Palese P, Shaw M . Broad-spectrum antiviral that interferes with de novo pyrimidine biosynthesis. Proc Natl Acad Sci U S A. 2011; 108(14):5777-82. PMC: 3078400. DOI: 10.1073/pnas.1101143108. View

5.
Chang K, Takahashi D, Prakash O, Kim Y . Characterization and inhibition of norovirus proteases of genogroups I and II using a fluorescence resonance energy transfer assay. Virology. 2011; 423(2):125-33. PMC: 3259199. DOI: 10.1016/j.virol.2011.12.002. View